Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis

Sarcoidosis is a systemic granulomatous disease with predominant manifestation in the lungs, often presenting as interstitial lung disease. Pulmonary function abnormalities in sarcoidosis include restriction of lung volumes, reduction in diffusing capacity of the lung for carbon monoxide (DL,CO), reduced static lung compliance (CL,s) and airway obstruction. The aim of the present study was to assess various lung function indices, including CL,s and DL,CO, as markers of functional abnormality in sarcoidosis patients. Results from 830 consecutive patients referred for lung function tests with a diagnosis of sarcoidosis (223 in stage I, 486 in stage II and 121 in stage III) were retreospectively analysed. The mean±sd age of the patients was 40±11 yrs; 18% were active smokers and 24% were former smokers. Normal total lung capacity was found in 772 (93%) patients. Of these cases, 24.5% had a low CL,s and 21.5% had a low DL,CO. At least one abnormality was observed in 39.3% of these patients, whereas, in restrictive patients, this figure was 88%. Airway obstruction was present in 11.7% of cases. Lung volumes usually remain within the normal range and measurement of either CL,s or DL,CO often reveal impaired lung function in sarcoidosis patients, even when their lung volumes are still in the normal range; these two measurements provide complementary information.

[1]  陶仲为 Sarcoidosis , 2009 .

[2]  W. Galetke,et al.  Reference values for dynamic and static pulmonary compliance in men. , 2007, Respiratory medicine.

[3]  S. Sorichter,et al.  Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. , 2006, Chest.

[4]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[5]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[6]  T. Peroš-Golubičić Sarcoidosis : Interstitial Lung Disease , 2005 .

[7]  M. Franczuk,et al.  Value of Spirometry in Detecting Volume Restriction in Interstitial Lung Disease Patients , 2004, Respiration.

[8]  P. Primatesta,et al.  Prediction equations for normal and low lung function from the Health Survey for England , 2004, European Respiratory Journal.

[9]  G. McLennan,et al.  Two year prognosis of sarcoidosis: the ACCESS experience. , 2003, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[10]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[11]  H. Magnussen,et al.  Noninvasive monitoring of airway inflammation. , 2000, The European respiratory journal.

[12]  E. Hoffman,et al.  Interstitial lung disease: A quantitative study using the adaptive multiple feature method. , 1999, American journal of respiratory and critical care medicine.

[13]  Statement on Sarcoidosis , 1999 .

[14]  B. Miller,et al.  Thoracic sarcoidosis: radiologic-pathologic correlation. , 1995, Radiographics : a review publication of the Radiological Society of North America, Inc.

[15]  J. Stocks,et al.  Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. , 1995, The European respiratory journal.

[16]  H. Robertson Clinical application of pulmonary function and exercise tests in the management of patients with interstitial lung disease , 1994 .

[17]  Strømskag Ke,et al.  Smoking does not prevent the onset of respiratory failure in sarcoidosis. , 1993 .

[18]  A. Eklund,et al.  Smoking does not prevent the onset of respiratory failure in sarcoidosis. , 1993, Sarcoidosis.

[19]  J. Zieliński,et al.  Airways obstruction in patients with sarcoidosis. , 1991, Sarcoidosis.

[20]  B. Harrison,et al.  Airflow limitation in sarcoidosis--a study of pulmonary function in 107 patients with newly diagnosed disease. , 1991, Respiratory medicine.

[21]  Z. Udwadia,et al.  Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction. , 1990, Thorax.

[22]  K. Sietsma Sarcoidosis and the diffusing capacity for carbon monoxide. , 1990, Sarcoidosis.

[23]  D. Rapoport,et al.  Volume adjustment of mechanics and diffusion in interstitial lung disease. Lack of clinical relevance. , 1989, Chest.

[24]  B. Jonson,et al.  Lung mechanics and their relationship to lung volumes in pulmonary sarcoidosis. , 1989, The European respiratory journal.

[25]  O. Sharma,et al.  Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis. , 1988, Chest.

[26]  D. Valeyre,et al.  Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. , 1988, Thorax.

[27]  O. Sharma,et al.  Airway obstruction in sarcoidosis. , 1988, The Western journal of medicine.

[28]  M. Lewis,et al.  Airflow obstruction in sarcoidosis. , 1987, Chest.

[29]  R. Govindarajan,et al.  Pulmonary sarcoidosis. , 1985, The Journal of the Association of Physicians of India.

[30]  A. Miller,et al.  Standardized lung function testing. , 1984, Bulletin europeen de physiopathologie respiratoire.

[31]  D. James,et al.  Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. , 1983, The Quarterly journal of medicine.

[32]  N. Konietzko,et al.  Airway hyperreactivity in patients with sarcoidosis. , 1982, The American review of respiratory disease.

[33]  N. Davies,et al.  Does the lung work? 4. What does the transfer of carbon monoxide mean? , 1982, British journal of diseases of the chest.

[34]  N. Lapp,et al.  The effect of diffuse pulmonary fibrosis on lung mechanics. , 1981, Bulletin europeen de physiopathologie respiratoire.

[35]  R. Crystal,et al.  Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us , 1980 .

[36]  R. Crystal,et al.  Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us? , 1980, Chest.

[37]  J. Yernault,et al.  Inspiratory muscle force in normal subjects and patients with interstitial lung disease. , 1980, Thorax.

[38]  N. Pride,et al.  Exponential description of the static pressure-volume curve of normal and diseased lungs. , 2015, The American review of respiratory disease.

[39]  I. Greaves,et al.  Exponential analysis of elastic recoil and aging in healthy males and females. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[40]  J D Fulmer,et al.  Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. , 1979, The Journal of clinical investigation.

[41]  C. Colp Sarcoidosis: course and treatment. , 1977, The Medical clinics of North America.

[42]  K. Kaneko,et al.  Airway obstruction in pulmonary sarcoidosis. , 1977, Bulletin europeen de physiopathologie respiratoire.

[43]  M. Altose,et al.  Airway function in sarcoidosis. , 1977, The American journal of medicine.

[44]  J. Yernault,et al.  Pulmonary mechanics in diffuse fibrosing alveolitis. , 1975, Bulletin de physio-pathologie respiratoire.

[45]  R. Bégin,et al.  Flow and age dependence of airway closure and dynamic compliance. , 1975, Journal of applied physiology.

[46]  P. Macklem,et al.  Early effects of asbestos exposure on lung function. , 1971, The American review of respiratory disease.

[47]  W. Stead,et al.  The relationship between maximum inspiratory pressure and total lung capcaity (coefficient of retraction) in normal patients and in patients with emphysema, asthma, and diffuse pulmonary infiltration. , 1968, Aspen Emphysema Conference.

[48]  W. Stead,et al.  Relationship between maximal inspiratory pressure and total lung capacity (coefficient of retraction) in normal subjects and in patients with emphysema, asthma, and diffuse pulmonary infiltration. , 2015, The American review of respiratory disease.